$ZLAB
Stock $zlab

$zlab Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000162828023016816 Filed on May 09, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022 Q1
Revenue	$62.80M	$62.60M	$46.72M
YoY Change	34.41%	41.73%	132.44%
Cost Of Revenue	$21.34M	$20.92M	$15.64M
YoY Change	36.43%	-3.58%	108.26%
Gross Profit	$41.46M	$41.68M	$31.08M
YoY Change	33.4%	85.48%	146.67%
Gross Profit Margin	66.02%	66.58%	66.52%
Selling, General & Admin	$62.51M	$72.02M	$56.99M
YoY Change	9.69%	3.51%	59.01%
% of Gross Profit	150.77%	172.81%	183.37%
Research & Development	$48.47M	$66.95M	$53.85M
YoY Change	-9.99%	-61.1%	-73.58%
% of Gross Profit	116.91%	160.63%	173.26%
Depreciation & Amortization	$2.657M	$2.127M	$2.010M
YoY Change	32.19%	13.14%	-295.15%
% of Gross Profit	6.41%	5.1%	6.47%
Operating Expenses	$111.0M	$139.0M	$110.9M
YoY Change	0.12%	-42.5%	-53.75%
Operating Profit	-$69.52M	-$97.29M	-$79.77M
YoY Change	-12.85%	-55.61%	-64.87%
Interest Expense	$19.14M	-$47.06M	$190.0K
YoY Change	9975.79%	-4713.33%	-9.52%
% of Operating Profit
Other Income/Expense, Net	$1.234M	$82.58M	-$2.600M
YoY Change	-147.46%	1103.79%	-58.27%
Pretax Income	-$49.14M	-$61.77M	-$82.17M
YoY Change	-40.19%	-70.77%	-64.75%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$49.14M	-$61.77M	-$82.39M
YoY Change	-40.35%	-70.84%	-64.63%
Net Earnings / Revenue	-78.26%	-98.67%	-176.35%
Basic Earnings Per Share	-$0.05		-$0.09
Diluted Earnings Per Share	-$0.05	-$0.06	-$86.23K
COMMON SHARES
Basic Shares Outstanding	961.4M shares		955.5M shares
Diluted Shares Outstanding	961.4M shares		955.5M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$930.4M	$1.008B	$1.312B
YoY Change	-29.1%	-28.43%	29.48%
Cash & Equivalents	$879.8M	$1.008B	$299.7M
Short-Term Investments	$50.55M	$0.00	$465.3M
Other Short-Term Assets	$42.77M	$35.67M	$16.50M
YoY Change	159.22%	98.19%	15.38%
Inventory	$38.41M	$31.62M	$20.30M
Prepaid Expenses
Receivables	$43.35M	$39.96M	$33.40M
Other Receivables	$17.38M	$8.608M	$10.80M
Total Short-Term Assets	$1.072B	$1.124B	$1.393B
YoY Change	-23.04%	-25.09%	32.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$58.31M	$57.86M	$62.20M
YoY Change	-6.26%	0.98%	36.11%
Goodwill
YoY Change
Intangibles	$1.479M	$1.511M
YoY Change		-18.24%
Long-Term Investments	$6.872M	$6.431M	$8.400M
YoY Change	-18.19%	-58.78%	460.0%
Other Assets	$4.048M	$3.595M	$6.700M
YoY Change	-39.58%	33.15%	252.63%
Total Long-Term Assets	$97.78M	$95.80M	$107.6M
YoY Change	-9.13%	-12.19%	31.06%
TOTAL ASSETS
Total Short-Term Assets	$1.072B	$1.124B	$1.393B
Total Long-Term Assets	$97.78M	$95.80M	$107.6M
Total Assets	$1.170B	$1.220B	$1.501B
YoY Change	-22.04%	-24.21%	32.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$66.36M	$65.97M	$98.20M
YoY Change	-32.42%	-47.72%	137.2%
Accrued Expenses	$18.79M	$38.74M	$23.10M
YoY Change	-18.66%	22.59%	73.68%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$124.6M	$139.8M	$154.9M
YoY Change	-19.59%	-27.51%	67.1%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$325.0K	$0.00	$38.00M
YoY Change	-99.14%	-100.0%	31.03%
Total Long-Term Liabilities	$325.0K	$0.00	$38.00M
YoY Change	-99.14%	-100.0%	31.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$124.6M	$139.8M	$154.9M
Total Long-Term Liabilities	$325.0K	$0.00	$38.00M
Total Liabilities	$168.8M	$174.5M	$192.9M
YoY Change	-12.48%	-24.11%	58.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.911B	-$1.861B
YoY Change		31.26%
Common Stock	$2.911B	$2.893B
YoY Change		2.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.001B	$1.046B	$1.308B
YoY Change
Total Liabilities & Shareholders Equity	$1.170B	$1.220B	$1.501B
YoY Change	-22.04%	-24.21%	32.67%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022 Q1
OPERATING ACTIVITIES
Net Income	-$49.14M	-$61.77M	-$82.39M
YoY Change	-40.35%	-70.84%	-64.63%
Depreciation, Depletion And Amortization	$2.657M	$2.127M	$2.010M
YoY Change	32.19%	13.14%	-295.15%
Cash From Operating Activities	-$69.29M	-$109.3M	-$87.13M
YoY Change	-20.48%	-28.56%	370.72%
INVESTING ACTIVITIES
Capital Expenditures	$3.513M	$4.373M	-$9.900M
YoY Change	-135.48%	-167.38%	-186.99%
Acquisitions
YoY Change
Other Investing Activities	-$50.44M	$0.00	-$20.25M
YoY Change	149.08%	-100.0%	-102.55%
Cash From Investing Activities	-$53.95M	-$4.373M	-$30.14M
YoY Change	79.01%	-98.45%	-103.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$300.0K
YoY Change			-100.14%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$3.886M	-199.0K	260.0K
YoY Change	-1594.62%	-28.93%	-100.12%
NET CHANGE
Cash From Operating Activities	-$69.29M	-109.3M	-87.13M
Cash From Investing Activities	-$53.95M	-4.373M	-30.14M
Cash From Financing Activities	-$3.886M	-199.0K	260.0K
Net Change In Cash	-$128.4M	-113.9M	-117.0M
YoY Change	9.76%	-73.81%	-120.56%
FREE CASH FLOW
Cash From Operating Activities	-$69.29M	-$109.3M	-$87.13M
Capital Expenditures	$3.513M	$4.373M	-$9.900M
Free Cash Flow	-$72.80M	-$113.7M	-$77.23M
YoY Change	-5.74%	-22.41%	158.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001704292
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-38205
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ZAI LAB LIMITED
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1144595
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4560 Jinke Road
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Bldg. 1, Fourth Floor, Pudong
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Shanghai
CY2023Q1	dei	Entity Address Country EntityAddressCountry	CN
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	201210
CY2023Q1	dei	City Area Code CityAreaCode	86 21
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	6163 2588
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	879844000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1008470000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	50550000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	43346000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39963000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent	17381000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent	8608000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	38405000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	31621000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	42772000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35674000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1072298000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1124336000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1003000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	803000	usd
CY2023Q1	us-gaap	Assets Assets	1170074000	usd
CY2022Q4	us-gaap	Assets Assets	1220140000	usd
CY2023Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	6872000	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	6431000	usd
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	6872000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	6431000	usd
CY2023Q1	zlab	Prepayments For Equipment PrepaymentsForEquipment	1721000	usd
CY2022Q4	zlab	Prepayments For Equipment PrepaymentsForEquipment	1396000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58309000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57863000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20148000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19512000	usd
CY2023Q1	zlab	Land Use Rights Net Noncurrent LandUseRightsNetNoncurrent	6920000	usd
CY2022Q4	zlab	Land Use Rights Net Noncurrent LandUseRightsNetNoncurrent	6892000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1479000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1511000	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	1324000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	1396000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	66361000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	65974000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7318000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7050000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	50881000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	66818000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	124560000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	139842000	usd
CY2023Q1	us-gaap	Deferred Income Noncurrent DeferredIncomeNoncurrent	30968000	usd
CY2022Q4	us-gaap	Deferred Income Noncurrent DeferredIncomeNoncurrent	21360000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12979000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13343000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	325000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2023Q1	us-gaap	Liabilities Liabilities	168832000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	174545000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000006
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000006
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	967197350	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	962455850	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	963688740	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	960219570	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	6000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	6000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2911454000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2893120000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1910504000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1861360000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	17272000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	25685000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3508610	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2236280	shares
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	16986000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	11856000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1001242000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1045595000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1170074000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1220140000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	62797000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	46095000	usd
CY2023Q1	us-gaap	Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer	0	usd
CY2022Q1	us-gaap	Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer	629000	usd
CY2023Q1	us-gaap	Revenues Revenues	62797000	usd
CY2022Q1	us-gaap	Revenues Revenues	46724000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	21337000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	15643000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	48472000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	53854000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	62510000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	56991000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-69522000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-79764000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	10232000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	188000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	8912000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2285000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1234000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4882000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-49144000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-82173000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-221000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-49144000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-82394000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-49144000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-49144000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-82394000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-82394000	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	961444780	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	961444780	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	955499030	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	955499030	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-49144000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-82394000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-8413000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2193000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-57557000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-84587000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1045595000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1673000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	5130000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16661000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-49144000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-8413000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2013000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1001242000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1379956000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	297000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	68000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12410000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-82394000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2193000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1308008000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-49144000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-82394000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	377000	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	138000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2657000	usd
CY2023Q1	zlab	Amortization Of Deferred Income AmortizationOfDeferredIncome	-582000	usd
CY2022Q1	zlab	Amortization Of Deferred Income AmortizationOfDeferredIncome	-708000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	16661000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12410000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-221000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	441000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-6939000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-64000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	11000	usd
CY2023Q1	zlab	Non Cash Lease Expenses NonCashLeaseExpenses	2464000	usd
CY2022Q1	zlab	Non Cash Lease Expenses NonCashLeaseExpenses	2017000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	8912000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	2285000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2852000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-14080000	usd
CY2023Q1	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	8599000	usd
CY2022Q1	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	3513000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6686000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1475000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6470000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1531000	usd
CY2023Q1	zlab	Increase Decrease In Long Term Deposits IncreaseDecreaseInLongTermDeposits	-72000	usd
CY2022Q1	zlab	Increase Decrease In Long Term Deposits IncreaseDecreaseInLongTermDeposits	71000	usd
CY2023Q1	zlab	Increase Decrease In Value Added Taxes Receivable IncreaseDecreaseInValueAddedTaxesReceivable	0	usd
CY2022Q1	zlab	Increase Decrease In Value Added Taxes Receivable IncreaseDecreaseInValueAddedTaxesReceivable	-3092000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-327000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-28002000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-15593000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-8837000	usd
CY2023Q1	zlab	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-2141000	usd
CY2022Q1	zlab	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-2389000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	9839000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	118000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	325000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-69287000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-87127000	usd
CY2023Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	100000000	usd
CY2022Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	120274000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	49450000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	100000000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	112000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	25000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3513000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9743000	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3000	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	152000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-53954000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30144000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1197000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	297000	usd
CY2023Q1	zlab	Employee Taxes Paid Related To Settlement Of Equity Awards EmployeeTaxesPaidRelatedToSettlementOfEquityAwards	-5083000	usd
CY2022Q1	zlab	Employee Taxes Paid Related To Settlement Of Equity Awards EmployeeTaxesPaidRelatedToSettlementOfEquityAwards	-39000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3886000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	258000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1299000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-130000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-128426000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-117143000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1009273000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	964903000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	880847000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	847760000	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	4232000	usd
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	668000	usd
CY2023Q1	zlab	Non Cash Payables For Intangible Assets NonCashPayablesForIntangibleAssets	268000	usd
CY2022Q1	zlab	Non Cash Payables For Intangible Assets NonCashPayablesForIntangibleAssets	73000	usd
CY2023Q1	zlab	Non Cash Payables For Treasury Stock NonCashPayablesForTreasuryStock	0	usd
CY2022Q1	zlab	Non Cash Payables For Treasury Stock NonCashPayablesForTreasuryStock	55000	usd
CY2023Q1	zlab	Noncash Receivables For Stock Options Exercised NoncashReceivablesForStockOptionsExercised	476000	usd
CY2022Q1	zlab	Noncash Receivables For Stock Options Exercised NoncashReceivablesForStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2662000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4596000	usd
CY2023Q1	zlab	Receivable Recognized For Disposal Of Property And Equipment ReceivableRecognizedForDisposalOfPropertyAndEquipment	10000	usd
CY2022Q1	zlab	Receivable Recognized For Disposal Of Property And Equipment ReceivableRecognizedForDisposalOfPropertyAndEquipment	0	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	879844000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	846957000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1003000	usd
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	803000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	880847000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	847760000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, accrual of rebates, recognition of research and development expenses to the appropriate financial reporting period based on the progress of the research and development projects, fair value of share-based compensation expenses, and recoverability of deferred tax assets. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates.
CY2023Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	878786000	usd
CY2022Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	1007423000	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1058000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1047000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	879844000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1008470000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	879844000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1008470000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	38400000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	31600000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17832000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12156000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	20521000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19029000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	52000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	436000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	38405000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	31621000	usd
CY2023Q1	zlab	Inventory Write Down Value InventoryWriteDownValue	400000	usd
CY2022Q1	zlab	Inventory Write Down Value InventoryWriteDownValue	100000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	82788000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	79927000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24479000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22064000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58309000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	31689000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57863000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	2500000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	1900000	usd
CY2023Q1	zlab	Revenue From Contract With Customers Excluding Assessed Tax Before Adjustments For Rebates And Sales Returns RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns	71212000	usd
CY2022Q1	zlab	Revenue From Contract With Customers Excluding Assessed Tax Before Adjustments For Rebates And Sales Returns RevenueFromContractWithCustomersExcludingAssessedTaxBeforeAdjustmentsForRebatesAndSalesReturns	53310000	usd
CY2023Q1	zlab	Revenue From Contract With Customers Excluding Assessed Tax Adjustments For Rebates And Sales Returns RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns	8415000	usd
CY2022Q1	zlab	Revenue From Contract With Customers Excluding Assessed Tax Adjustments For Rebates And Sales Returns RevenueFromContractWithCustomersExcludingAssessedTaxAdjustmentsForRebatesAndSalesReturns	7215000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	62797000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	46095000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	62797000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	46095000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11472000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7148000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4080000	usd
CY2023Q1	zlab	Payables For Purchase Of Property And Equipment Current PayablesForPurchaseOfPropertyAndEquipmentCurrent	4232000	usd
CY2022Q4	zlab	Payables For Purchase Of Property And Equipment Current PayablesForPurchaseOfPropertyAndEquipmentCurrent	5269000	usd
CY2023Q1	zlab	Accrued Rebate To Distributors Current AccruedRebateToDistributorsCurrent	11536000	usd
CY2022Q4	zlab	Accrued Rebate To Distributors Current AccruedRebateToDistributorsCurrent	8443000	usd
CY2023Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	13001000	usd
CY2022Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	13283000	usd
CY2023Q1	zlab	Other Payables Current Liabilities OtherPayablesCurrentLiabilities	3492000	usd
CY2022Q4	zlab	Other Payables Current Liabilities OtherPayablesCurrentLiabilities	4054000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	50881000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	66818000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-49144000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-49144000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-82394000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-82394000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	961444780	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	961444780	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	955499030	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	955499030	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16661000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12410000	usd
CY2023Q1	zlab	Cash Grants Recorded In Other Income CashGrantsRecordedInOtherIncome	0	usd
CY2022Q1	zlab	Cash Grants Recorded In Other Income CashGrantsRecordedInOtherIncome	1576000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	441000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-6939000	usd
CY2023Q1	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	793000	usd
CY2022Q1	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	481000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1234000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4882000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001628280-23-016816-index-headers.html	Edgar Link	pending
0001628280-23-016816-index.html	Edgar Link	pending
0001628280-23-016816.txt	Edgar Link	pending
0001628280-23-016816-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zlab-20230331.htm	Edgar Link	pending
zlab-20230331.xsd	Edgar Link	pending
zlab-20230331x10qxexx311.htm	Edgar Link	pending
zlab-20230331x10qxexx312.htm	Edgar Link	pending
zlab-20230331x10qxexx321.htm	Edgar Link	pending
zlab-20230331x10qxexx322.htm	Edgar Link	pending
zlab-20230331_g1.jpg	Edgar Link	pending
zlab-20230331_def.xml	Edgar Link	unprocessable
zlab-20230331_cal.xml	Edgar Link	unprocessable
zlab-20230331_pre.xml	Edgar Link	unprocessable
zlab-20230331_lab.xml	Edgar Link	unprocessable
zlab-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZLAB
Stock $zlab

2023 Q1 Form 10-Q Financial Statement

#000162828023016816 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZLAB Stock $zlab

2023 Q1 Form 10-Q Financial Statement

#000162828023016816 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZLAB
Stock $zlab